Evidence map›Paper›PMID 20211730›Full record

ReviewMethods (San Diego, Calif.)2010

Transposon transgenesis in Xenopus.

Donald A Yergeau, Clair M Kelley, Haiqing Zhu, Emin Kuliyev, Paul E Mead

Open access · greenAbstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Frontiers in physiology · 2019
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Donald A YergeauDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Clair M Kelley
Haiqing Zhu
Emin Kuliyev
Paul E Mead
St. Jude Children's Research Hospital · US

Funding

Insertional Mutagenesis Strategies in Xenopus tropicalisR01HD042294 · NICHD · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MEAD, PAUL E · 2002 to 2006
$1.9M
Tol2-mediated gene and enhancer trapping in Xenopus tropicalisR01MH079381 · NIMH · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MEAD, PAUL E · 2009 to 2010
$852k
NICHD NIH HHS R01 HD042294NICHD NIH HHS R01 HD42294NIMH NIH HHS R01 MH079381
6 · The paper itself

Abstract

Transposon-mediated integration strategies in Xenopus offer simple and robust methods for the generation of germline transgenic animals. Co-injection of fertilized one-cell embryos with plasmid DNA harboring a transposon transgene and synthetic mRNA encoding the cognate transposase enzyme results in mosaic integration of the transposon at early cleavage stages that are frequently passed through the germline in the adult animal. Micro-injection of fertilized embryos is a routine procedure used by many laboratories that use Xenopus as a developmental model and, as such, the transposon transgenesis method can be performed without additional equipment or specialized methodologies. The methods for injecting Xenopus embryos are well documented in the literature so here we provide a step-by-step guide to other aspects of transposon transgenesis, including screening mosaic founders for germline transmission of the transgene and general husbandry considerations related to management of populations of transgenic frogs.

Indexed as

DNA Transposable ElementsAnimalsAnimals, Genetically ModifiedBacteriophagesCrosses, GeneticDNAGene SilencingOocytesPlasmidsPolymerase Chain ReactionTransgenesTransposasesXenopusDNADNA Transposable ElementsTransposases

Identifiers

PMID20211730
PMCPMC2879075
OpenAlexW2076870585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.